DiaMedica Therapeutics Inc (DMAC) — Long-term Investment Intensity

Latest as of March 2025: 2.6%

DiaMedica Therapeutics Inc (DMAC) has a Long-term Investment Intensity of 2.6% as of March 2025. Long-term investments of $1.00 Million represent 2.6% of total assets of $38.83 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check DiaMedica Therapeutics Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

2.6%
LT Investments / Total Assets

Long-term Investments

$1.00 Million
USD

Total Assets

$38.83 Million
USD

Country

USA
NASDAQ

Annual Long-term Investment Intensity for DiaMedica Therapeutics Inc (None–None)

The table below presents the year-by-year Long-term Investment Intensity for DiaMedica Therapeutics Inc from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read DiaMedica Therapeutics Inc balance sheet liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
pp = percentage points